10.18.2019 - By ReachMD
Host: Matt Birnholz, MD
Guest: Hans Petter Eikesdal, MD
At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.